A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
Clinical trial NCT06511570 · COMPLETED
Trial details
- NCT number
- NCT06511570
- Sponsor
- Acumen Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2024-09-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.